|
1
|
Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys.
|
Toxicol Pathol
|
2007
|
1.52
|
|
2
|
Rheumatoid factor interference in immunogenicity assays for human monoclonal antibody therapeutics.
|
J Immunol Methods
|
2010
|
1.05
|
|
3
|
Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF in rhesus monkeys.
|
Toxicol Pathol
|
2007
|
0.99
|
|
4
|
Epitope characterization of pre-existing and developing antibodies to an aglycosylated monoclonal antibody therapeutic of G1m17,1 allotype.
|
J Immunol Methods
|
2012
|
0.97
|
|
5
|
Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion.
|
J Clin Immunol
|
2007
|
0.96
|
|
6
|
Strategic characterization of anti-drug antibody responses for the assessment of clinical relevance and impact.
|
Bioanalysis
|
2014
|
0.77
|